rHEALTH LLC and DNA Medicine Institute (DMI) announce a USPTO Notice of Allowance for their innovative microvolume sample consumable and loader, enhancing reproducibility and ease-of-use for point-of-care diagnostics.

Dr. Eugene Chan will present rHEALTH’s advanced blood sensor and SKYE Sensor technology at NASA’s Human Research Program Investigator’s Workshop, highlighting innovations in comprehensive biomedical monitoring for long-duration space missions.

rHEALTH LLC and DNA Medicine Institute (DMI) announce a Notice of Allowance from the USPTO for a patent enabling highly multiplexed diagnostic testing in small-volume samples, further advancing at-home and point-of-care health monitoring.

rHEALTH LLC and DNA Medicine Institute (DMI) announce three new U.S. patents for innovations in biochemistry and micro-volume sampling, further enhancing the analytic power and sophistication of the rHEALTH diagnostic platform.

DMI Founder Dr. Eugene Chan will present the innovative rHEALTH diagnostic platform at the 69th Annual Scientific Meeting of the American Association for Clinical Chemistry (AACC) in San Diego, highlighting its cutting-edge capabilities in biomedical analysis.

rHEALTH LLC and DNA Medicine Institute (DMI) announce a new U.S. patent for their innovative optical block technology, enhancing the precision and portability of point-of-care biomedical diagnostics.

DNA Medicine Institute (DMI) and rHEALTH LLC announce a collaborative effort with NASA and the U.S. Air Force to develop portable, wireless health monitoring devices, including the rHEALTH small-volume blood analyzer and SKYE Sensor vitals monitor.

rHEALTH LLC and DNA Medicine Institute (DMI) announce a new U.S. design patent for a cutting-edge vital sign monitoring instrument, reinforcing their leadership in portable, non-invasive, and continuous digital health solutions.

At NASA’s 2016 Human Research Program Investigator’s Workshop, DMI founder Dr. Eugene Y. Chan highlighted the rHEALTH X platform’s groundbreaking capabilities in non-invasive vital monitoring and blood-based biomarker analysis for space and terrestrial applications.

The DNA Medicine Institute (DMI) celebrates the USPTO patent issuance for the rHEALTH ONE, recognizing its compact, low-power design and groundbreaking capabilities in microvolume biomarker and cell analysis.

The DNA Medicine Institute (DMI) secures NIH funding to further develop its STAT blood sensor, a groundbreaking technology that delivers comprehensive blood counts from just a single drop—paving the way for rapid diagnostics in clinics, emergency settings, and the field.

At the 2015 AACC Annual Meeting, Dr. Eugene Chan’s talk on rHEALTH technology earned him the Outstanding Speaker Award, recognizing his exceptional contribution to continuing education in clinical chemistry.